Unresolved problems in venous thromboembolism treatment in cancer


https://doi.org/10.4081/hmr.v1i9.335
Vol. 1 No. 9: 3rd International Conference on Thrombosis and Hemostasis Issues in Cancer, Bergamo, October 14-16, 2005
Published: June 3, 2009
Abstract Views: 136
PDF: 364
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Venous thromboembolism (VTE) is a common complication in cancer patients. Prevention and treatment of VTE are major issues in cancer patients. For prophylaxis in the surgical setting, once-daily subcutaneous injections of low molecular weight heparin (LMWHs) are as effective and safe as multiple doses of unfractionated heparin (UFH). Extending prophylaxis with LMWH beyond hospital discharge reduces the risk of postoperative thrombosis after abdominal surgery for cancer. The clinical benefit from antithrombotic prophylaxis in medical cancer patients remains uncertain. For the initial treatment of VTE, LMWHs are effective and safe. For the long-term treatment of VTE, LMWHs have been shown to be more effective than the vitamin K antagonists in preventing recurrent VTE in cancer patients. The preliminary observations that LMWHs are associated with reduction in cancer mortality deserve further interest.

Supporting Agencies


Agnelli, A., & Verso, M. (2009). Unresolved problems in venous thromboembolism treatment in cancer. Hematology Meeting Reports (formerly Haematologica Reports), 1(9). https://doi.org/10.4081/hmr.v1i9.335
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC